FDA announces meetings on ag biotech educational outreach

Meetings planned for Charlotte and San Francisco in November to allow public to share information on biotechnology outreach initiative.

When Congress passed the biotech labeling law in 2016, it also appropriated $3 million to fund the Agricultural Biotechnology Education & Outreach Initiative, which calls upon the Food & Drug Administration to work with the U.S. Department of Agriculture to provide education and outreach to the public on agricultural biotechnology as well as food and animal feed ingredients derived from biotechnology.

FDA announced that two public meetings are scheduled for Charlotte, N.C., and San Francisco, Cal., to provide the public with an opportunity to share information, experiences and suggestions to help inform the development of this educational and outreach initiative.

The initial phase of this initiative is to inform the public of FDA’s work and obtain input from all stakeholders on the issue.

The Charlotte meeting is planned for 8 a.m. to 1 p.m. (EST) Nov. 7 at the Omni Charlotte Hotel. The San Francisco meeting is scheduled for 8 a.m. to 1 p.m. (PST) Nov. 14 at the San Francisco Marriott Marquis.

The goal of this initiative is to provide consumer outreach and education through publication and distribution of science-based educational information on the environmental, nutritional, food safety, economic and humanitarian impacts of agricultural biotechnology. FDA is currently working on this initiative in consultation with USDA and other federal agencies.

A webcast will be available for both meetings for those who cannot attend in person.

For questions about registering for the meetings or to register via email, mail or FAX, contact Simone Katz, Strategic Results, 101 Lakeforest Blvd., Suite 390, Gaithersburg, MD 20877; phone (240) 449-8427; FAX (240) 641-9042, or email [email protected].

FDA is accepting public comments on questions listed in the Federal Register notice. Comments may be submitted beginning Oct. 13, 2017, and will be accepted until Nov. 17, 2017.

To submit comments to the docket electronically, visit www.regulations.gov, and type FDA-2017-N-5991 in the search box.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.